GHSI - צמיחת מכירות משנה לשנה (TTM) Guardion Health Science

The LTM sales growth YoY metric on the GURU.Markets terminal linear chart correlates with the outsourcing of production and logistics to external partners, while the 10.00 level indicates the parameter's status. Guardion Health Science (GHSI) is currently focused on winding down its structure and returning capital to shareholders following the divestiture of its core brands. A steady revenue stream from the sale of eye nutraceuticals provides the company with high margins.

This indicator measures revenue growth rates on a rolling year basis, neutralizing quarterly gaps and assessing the business's ability to index prices while maintaining demand. By analyzing the trend of sales figures versus the same period last year over a rolling 12-month window, an investor determines the resilience of Guardion Health Science (GHSI) amid strict FDA and FTC oversight, where growth confirms the effectiveness of patents for specialized nutrition.